Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC.

Autor: Rosano GMC; Chair of Pharmacology, Department of Human Sciences and Promotion of Quality of Life, San Raffaele University of Rome, Rome, Italy.; Cardiology, San Raffaele Cassino Hospital, Cassino, Italy., Stolfo D; Division of Cardiology, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy.; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Anderson L; Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St. George's University of London and St George's University Hospitals NHS Foundation Trust, London, UK., Abdelhamid M; Department of Cardiovascular Medicine, Faculty of Medicine, Kasr Al Ainy, Cairo University, Giza, Egypt., Adamo M; ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy., Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany., Bayes-Genis A; Heart Institute, Hospital Universitari Germans Trias i Poujol, CIBERCV, Badalona, Spain., Böhm M; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany., Chioncel O; University of Medicine Carol Davila, Bucharest, Romania.; Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania., Filippatos G; National & Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Chaidari, Greece., Hill L; School of Nursing and Midwifery, Queen's University, Belfast, UK., Lainscak M; Division of Cardiology, General Hospital Murska Sobota, Rakičan, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Lambrinou E; Department of Nursing, Cyprus University of Technology, Limassol, Cyprus., Maas AHEM; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Massouh AR; Hariri School of Nursing, American University of Beirut, Beirut, Lebanon., Moura B; Armed Forces Hospital, Porto, Portugal.; Faculty of Medicine of University of Porto, Porto, Portugal., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Rakisheva A; City Cardiological Center, Almaty Kazakhstan Qonaev city hospital, Almaty Region, Kazakhstan., Ray R; Department of Cardiology, St George's Hospital, London, UK., Savarese G; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Heart and Vascular and Neuro Theme, Karolinska University Hospital, Stockholm, Sweden., Skouri H; Division of Cardiology, Sheikh Shakhbout Medical city, Abu Dhabi, UAE., Van Linthout S; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner site Berlin, Berlin, Germany., Vitale C; Department of Cardiology, St George's Hospital, London, UK., Volterrani M; Department of Human Science and Promotion of Quality of Life, San Raffaele Open University, Rome, Italy.; Cardio-Pulmonary Department, IRCCS San Raffaele, Rome, Italy., Metra M; ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy., Coats AJS; Heart Research Institute, Sydney, NSW, Australia.
Jazyk: angličtina
Zdroj: European journal of heart failure [Eur J Heart Fail] 2024 Aug; Vol. 26 (8), pp. 1669-1686. Date of Electronic Publication: 2024 May 23.
DOI: 10.1002/ejhf.3284
Abstrakt: Despite the progress in the care of individuals with heart failure (HF), important sex disparities in knowledge and management remain, covering all the aspects of the syndrome, from aetiology and pathophysiology to treatment. Important distinctions in phenotypic presentation are widely known, but the mechanisms behind these differences are only partially defined. The impact of sex-specific conditions in the predisposition to HF has gained progressive interest in the HF community. Under-recruitment of women in large randomized clinical trials has continued in the more recent studies despite epidemiological data no longer reporting any substantial difference in the lifetime risk and prognosis between sexes. Target dose of medications and criteria for device eligibility are derived from studies with a large predominance of men, whereas specific information in women is lacking. The present scientific statement encompasses the whole scenario of available evidence on sex-disparities in HF and aims to define the most challenging and urgent residual gaps in the evidence for the scientific and clinical HF communities.
(© 2024 European Society of Cardiology.)
Databáze: MEDLINE
Externí odkaz: